Biological evaluation of pyridone alkaloids on the endocannabinoid system

Bioorganic & Medicinal Chemistry
2017.0

Abstract

Naturally occurring pyridone alkaloids as well as synthetic derivatives were previously shown to induce neurite outgrowth. However, the molecular basis for this biological effect remains poorly understood. In this work, we have prepared new pyridones, and tested the effect of thirteen 4-hydroxy-2-pyridone derivatives on the components of the endocannabinoid system. Investigation of binding affinities towards CB1 and CB2 receptors led to the identification of a compound binding selectively to CB1 (12). Compound 12 and a closely related derivative (11) also inhibited anandamide (AEA) hydrolysis by fatty acid amide hydrolase. Interestingly, none of the compounds tested showed any effect on 2-AG hydrolysis by monoacylglycerol lipase at 10 μM. Assessment of AEA uptake did, however, lead to the identification of four inhibitors with IC50 values in the submicromolar range and high selectivity over the other components of the endocannabinoid system. © 2017 Elsevier Ltd

Knowledge Graph

Similar Paper

Biological evaluation of pyridone alkaloids on the endocannabinoid system
Bioorganic & Medicinal Chemistry 2017.0
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system
European Journal of Medicinal Chemistry 2018.0
Fatty Acid Amide Hydrolase Inhibitors from Virtual Screening of the Endocannabinoid System
Journal of Medicinal Chemistry 2006.0
Oxygenated Metabolites of Anandamide and 2-Arachidonoylglycerol:  Conformational Analysis and Interaction with Cannabinoid Receptors, Membrane Transporter, and Fatty Acid Amide Hydrolase
Journal of Medicinal Chemistry 2002.0
Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 Receptor
Journal of Medicinal Chemistry 2011.0
Design, Synthesis, and Binding Studies of New Potent Ligands of Cannabinoid Receptors
Journal of Medicinal Chemistry 2005.0
Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists
Bioorganic & Medicinal Chemistry Letters 2009.0
Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors
Bioorganic & Medicinal Chemistry Letters 2003.0
Structure–affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist
Bioorganic & Medicinal Chemistry 2014.0
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking
European Journal of Medicinal Chemistry 2017.0